共 25 条
- [21] First-line (1L) nivolumab (N) plus ipilimumab (I) with 2 cycles of platinum-based chemotherapy (C) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC): Results from an interim analysis of the German non-interventional study (NIS) FINN ANNALS OF ONCOLOGY, 2024, 35 : S852 - S852